DTaP, DPT, Diphtheria, Pertussis & Tetanus


Aloe, C. F. (2016). The Correlation of Nonmedical Vaccine Exemptions and Clusters of Pertussis Cases in the United States, 2012 (Doctoral dissertation). Retrieved from: http://nrs.harvard.edu/urn-3:HUL.InstRepos:33797295

Barlow, R. S., Reynolds, L. E., Cieslak, P. R., & Sullivan, A. D. (2014). Vaccinated children and adolescents with pertussis infections experience reduced illness severity and duration, Oregon, 2010–2012. Clinical Infectious Diseases, 58(11), 1523-1529.

Baxter, R., Bartlett, J., Fireman, B., Lewis, E., & Klein, N. P. (2017). Effectiveness of vaccination during pregnancy to prevent infant pertussis. Pediatrics, 139(5), e20164091.

Becker-Dreps, S., Butler, A. M., McGrath, L. J., Boggess, K. A., Weber, D. J., Li, D., … & Layton, J. B. (2018). Effectiveness of prenatal tetanus, diphtheria, acellular pertussis vaccination in the prevention of infant pertussis in the US. American journal of preventive medicine, 55(2), 159-166.

Bisgard, K. M., Pascual, F. B., Ehresmann, K. R., Miller, C. A., Cianfrini, C., Jennings, C. E., … & Lett, S. M. (2004). Infant pertussis: who was the source?. The Pediatric infectious disease journal, 23(11), 985-989.

Bisgard, K. M., Hardy, I. R., Popovic, T., Strebel, P. M., Wharton, M., Chen, R. T., & Hadler, S. C. (1998). Respiratory diphtheria in the United States, 1980 through 1995. American journal of public health, 88(5), 787-791.

Bisgard, K. M., Rhodes, P., Hardy, I. R., Litkina, I. L., Filatov, N. N., Monisov, A. A., & Wharton, M. (2000). Diphtheria toxoid vaccine effectiveness: a case-control study in Russia. Journal of Infectious Diseases, 181(Supplement_1), S184-S187.

Blennow, M., & Granström, M. (1989). Adverse reactions and serologic response to a booster dose of acellular pertussis vaccine in children immunized with acellular or whole-cell vaccine as infants. Pediatrics, 84(1), 62-67.

Carbonetti, N. H. (2010). Pertussis toxin and adenylate cyclase toxin: key virulence factors of Bordetella pertussis and cell biology tools. Future microbiology, 5(3), 455-469.

Chen, R. T., Hardy, I. R., Rhodes, P. H., Tyshchenko, D. K., Moiseeva, A. V., & Marievsky, V. F. (2000). Ukraine, 1992: first assessment of diphtheria vaccine effectiveness during the recent resurgence of diphtheria in the former Soviet Union. Journal of Infectious Diseases, 181(Supplement_1), S178-S183.

Centers for Disease Control and Prevention. (1982). International notes pertussis- England and Wales. Morbidity and Mortality Weekly Report; 31(47), 629-631. Retrieved from: https://www.cdc.gov/mmwr/preview/mmwrhtml/00001197.htm

Cody, C. L., Baraff, L. J., Cherry, J. D., Marcy, S. M., & Manclark, C. R. (1981). Nature and rates of adverse reactions associated with DTP and DT immunizations in infants and children. Pediatrics, 68(5), 650-660.

Duszynski, K. M., Pratt, N. L., Lynch, J. W., Berry, J. G., Gold, M. S., & Vaccine Assessment Using Linked Data (VALiD) Working Group. (2019). Use of different combination diphtheria-tetanus-acellular pertussis vaccines does not increase risk of 30-day infant mortality. A population-based linkage cohort study using administrative data from the Australian Childhood Immunisation Register and the National Death Index. Vaccine, 37(2), 280-288.

Galazka, A. M., Robertson, S. E., & Oblapenko, G. P. (1995). Resurgence of diphtheria. European journal of epidemiology, 11(1), 95-105.

Gale, J. L., Thapa, P. B., Wassilak, S. G., Bobo, J. K., Mendelman, P. M., & Foy, H. M. (1994). Risk of serious acute neurological illness after immunization with diphtheria-tetanus-pertussis vaccine: a population-based case-control study. Jama, 271(1), 37-41.

Glaxo-Smith Kline. (2005). BOOSTRIX (Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed) [PDF]. Retrieved from: https://gsksource.com/pharma/content/dam/GlaxoSmithKline/US/en/Prescribing_Information/Boostrix/pdf/BOOSTRIX.PDF

GlaxoSmithKline Biologicals. (2018).  KINRIX (Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine) [PDF]. Retrieved from: https://www.gsksource.com/pharma/content/dam/GlaxoSmithKline/US/en/Prescribing_Information/Kinrix/pdf/KINRIX.PDF

Griffin, M. R., Ray, W. A., Livengood, J. R., & Schaffner, W. (1988). Risk of sudden infant death syndrome after immunization with the diphtheria–tetanus–pertussis vaccine. New England Journal of Medicine, 319(10), 618-623.

Guzman-Cottrill, J. A., Lancioni, C., Eriksson, C., Cho, Y. J., & Liko, J. (2019). Notes from the field: tetanus in an unvaccinated child—Oregon, 2017. Morbidity and Mortality Weekly Report, 68(9), 231.

Hansen, J., Timbol, J., Lewis, N., Pool, V., Decker, M. D., Greenberg, D. P., & Klein, N. P. (2016). Safety of DTaP-IPV/Hib vaccine administered routinely to infants and toddlers. Vaccine, 34(35), 4172-4179.

Imdad, A., Tserenpuntsag, B., Blog, D. S., Halsey, N. A., Easton, D. E., & Shaw, J. (2013). Religious exemptions for immunization and risk of pertussis in New York State, 2000–2011. Pediatrics, 132(1), 37-43.

Kharbanda, E. O., Vazquez-Benitez, G., Lipkind, H. S., Klein, N. P., Cheetham, T. C., Naleway, A. L., … & McCarthy, N. (2016). Maternal Tdap vaccination: coverage and acute safety outcomes in the vaccine safety datalink, 2007–2013. Vaccine, 34(7), 968-973.

Khan, A. A., Zahidie, A., & Rabbani, F. (2013). Interventions to reduce neonatal mortality from neonatal tetanus in low and middle income countries-a systematic review. BMC Public Health, 13(1), 322.

Kuno‐Sakai, H., & Kimura, M. (2004). Safety and efficacy of acellular pertussis vaccine in Japan, evaluated by 23 years of its use for routine immunization. Pediatrics international, 46(6), 650-655.

McMillan, M., Clarke, M., Parrella, A., Fell, D. B., Amirthalingam, G., & Marshall, H. S. (2017). Safety of tetanus, diphtheria, and pertussis vaccination during pregnancy. Obstetrics & Gynecology, 129(3), 560-573.

Moore, D. L., Le Saux, N., Scheifele, D., Halperin, S. A., & Canadian Paediatric Society/Health Canada Immunization Monitoring Program Active (IMPACT. (2004). Lack of evidence of encephalopathy related to pertussis vaccine: active surveillance by IMPACT, Canada, 1993–2002. The Pediatric infectious disease journal, 23(6), 568-571.

Moro, P. L., Perez-Vilar, S., Lewis, P., Bryant-Genevier, M., Kamiya, H., & Cano, M. (2018). Safety surveillance of diphtheria and tetanus toxoids and acellular pertussis (DTaP) vaccines. Pediatrics, 142(1), e20174171.

Müller-Nordhorn, J., Hettler-Chen, C. M., Keil, T., & Muckelbauer, R. (2015). Association between sudden infant death syndrome and diphtheria-tetanus-pertussis immunisation: an ecological study. BMC pediatrics, 15(1), 1.

Noble, G. R., Bernier, R. H., Esber, E. C., Hardegree, M. C., Hinman, A. R., Klein, D., & Saah, A. J. (1987). Acellular and whole-cell pertussis vaccines in Japan: report of a visit by US scientists. JAMA, 257(10), 1351-1356.

Olin, P., Gustafsson, L., Barreto, L., Hessel, L., Mast, T. C., Van Rie, A., … & Storsaeter, J. (2003). Declining pertussis incidence in Sweden following the introduction of acellular pertussis vaccine. Vaccine, 21(17-18), 2015-2021.

Petousis-Harris, H., Walls, T., Watson, D., Paynter, J., Graham, P., & Turner, N. (2016). Safety of Tdap vaccine in pregnant women: an observational study. BMJ open, 6(4), e010911.

Phadke, V. K., Bednarczyk, R. A., Salmon, D. A., & Omer, S. B. (2016). Association between vaccine refusal and vaccine-preventable diseases in the United States: a review of measles and pertussis. Jama, 315(11), 1149-1158.

Ray, P., Hayward, J., Michelson, D., Lewis, E., Schwalbe, J., Black, S., … & Mullooly, J. (2006). Encephalopathy after whole-cell pertussis or measles vaccination: lack of evidence for a causal association in a retrospective case–control study. The Pediatric infectious disease journal, 25(9), 768-773.

Romanus, V., Jonsell, R., & Bergquist, S. O. (1987). Pertussis in Sweden after the cessation of general immunization in 1979. The Pediatric infectious disease journal, 6(4), 364-371.

Sanofi Pasteur, Inc. (2005). Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed: Tripedia. [PDF]. Retrieved from: https://www.vaccineshoppe.com/assets/pdf/tripedia

Sanofi Pasteur. Adacel (2019) (Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed) [PDF]. Retrieved from: https://www.fda.gov/downloads/biologicsbloodvaccines/vaccines/approvedproducts/ucm142764.pdf

Schmitt, H. J., Schuind, A., Knuf, M., Beutel, K., Schulte-Wissermann, H., Gahr, M., … & Bork, H. L. (1996). Clinical experience of a tricomponent acellular pertussis vaccine combined with diphtheria and tetanus toxoids for primary vaccination in 22,505 infants. The Journal of pediatrics, 129(5), 695-701.

Schwartz, K. L., Kwong, J. C., Deeks, S. L., Campitelli, M. A., Jamieson, F. B., Marchand-Austin, A., … & Drews, S. J. (2016). Effectiveness of pertussis vaccination and duration of immunity. CMAJ, 188(16), E399-E406.

Skoff, T. H., Kenyon, C., Cocoros, N., Liko, J., Miller, L., Kudish, K., … & Martin, S. W. (2015). Sources of infant pertussis infection in the United States. Pediatrics, 136(4), 635-641.

Skoff, T. H., Blain, A. E., Watt, J., Scherzinger, K., McMahon, M., Zansky, S. M., … & Martin, S. W. (2017). Impact of the US maternal tetanus, diphtheria, and acellular pertussis vaccination program on preventing pertussis in infants< 2 months of age: a case-control evaluation. Clinical Infectious Diseases, 65(12), 1977-1983.

Taranger, J., Trollfors, B., Bergfors, E., Knutsson, N., Sundh, V., Lagergård, T., … & Fusco, J. (2001). Mass vaccination of children with pertussis toxoid—decreased incidence in both vaccinated and nonvaccinated persons. Clinical infectious diseases, 33(7), 1004-1009.

Thierry-Carstensen, B., Jordan, K., Uhlving, H. H., Dalby, T., Sørensen, C., Jensen, A. M., & Heilmann, C. (2012). A randomised, double-blind, non-inferiority clinical trial on the safety and immunogenicity of a tetanus, diphtheria and monocomponent acellular pertussis (TdaP) vaccine in comparison to a tetanus and diphtheria (Td) vaccine when given as booster vaccinations to healthy adults. Vaccine, 30(37), 5464-5471.

Trollfors, B., & Rabo, E. (1981). Whooping cough in adults. Br Med J (Clin Res Ed), 283(6293), 696-697.

Van Rie, A., Wendelboe, A. M., & Englund, J. A. (2005). Role of maternal pertussis antibodies in infants. The Pediatric infectious disease journal, 24(5), S62-S65.

Wiley, K. E., Zuo, Y., Macartney, K. K., & McIntyre, P. B. (2013). Sources of pertussis infection in young infants: a review of key evidence informing targeting of the cocoon strategy. Vaccine, 31(4), 618-625.